With such clinical features, it is important to confirm a defect in ADAMTS13 activity in order to diagnose TTP.[8] It can be difficult to await confirmation of ADAMTS13 results before starting the management of TTP in emergent situations. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.